Term |
Tasurgratinib
See Operational Attributes
- Created on: 08/06/2020 15:12:21 by SMS
- Modified on: 01/08/2023 06:38:54 by SMS
- Revision number: 8
|
Identifier |
300000022204 |
Status |
Current |
Term Name |
Tasurgratinib
See Operational Attributes
-
Translation Status:
Current
-
Modified on:
22/03/2023 08:31:48 by SMS
Tasurgratinib
See Operational Attributes
-
Translation Status:
Current
-
Modified on:
22/03/2023 08:31:48 by SMS
|
Domain |
Human use - H
|
Visibility |
PUBLIC |
|
Source of Information Extended EudraVigilance Medicinal Product Dictionary - xEVMPD Source Term ID SUB214919 |
Term Name |
|
Substance Other Name |
5-((2-((4-(1-(2-hydroxyethyl)-4-piperidinyl)benzoyl)amino)-4-pyridinyl)oxy)-6-(2-methoxyethoxy)-N-methyl-1H-indole-1-carboxamide Source FDA SUBSTANCE REGISTRATION SYSTEM
See Operational Attributes
-
Translation Status:
Current
-
Modified on:
10/09/2021 11:09:11 by SMS
|
Substance Other Name |
|
Substance Other Name |
5-((2-(((4-(1-(2-hydroxyethyl)piperidin-4-yl)phenyl)carbonyl)amino)pyridin-4-yl)oxy)-6-(2-methoxyethoxy)-N-methyl-1H-indole-1-carboxamide Source FDA SUBSTANCE REGISTRATION SYSTEM
See Operational Attributes
-
Translation Status:
Current
-
Modified on:
08/06/2020 17:22:22 by SMS
|
Substance type |
Chemicals
|
Authorisation State |
AUTHORISED |
Substance Molecular Formulas |
C32H37N5O6
|